Endocrine
AKT · Endocrine/Breast

Fibroadenoma

Benign proliferation of breast lobular stroma + epithelium

Overview

The commonest benign breast tumour, typically in women under 35 — a smooth, firm, highly mobile, painless lump ('breast mouse'). Confirmed on triple assessment; most are left alone and many regress, with excision for large/growing/symptomatic lesions or patient choice.

Recognise

  • Young woman (often <35); smooth, firm, well-defined, highly MOBILE, painless lump
  • Usually <3 cm; may be multiple; oestrogen-sensitive (can grow in pregnancy)
  • Benign — no skin/nipple change, no fixation

Red flags

  • Rapidly growing/large (>3–4 cm) lesion → consider phyllodes tumour (excise)
  • Atypia on biopsy / family history → individualised management

Differentials & how to tell them apart

Breast cancerhard, irregular, fixed, skin/nipple change, older — fibroadenoma is mobile, smooth, young
Phyllodes tumourlarger, rapidly growing fibroepithelial lesion — can be borderline/malignant, needs wide excision
Breast cystfluctuant, may be tender, resolves on aspiration

Investigations

Triple assessment (age-appropriate): ultrasound (well-defined) ± mammography in older women; core biopsy if ≥25 or atypical.

Management

Reassurance/observation after triple assessment (excise if large/growing/symptomatic)

  1. 1Confirm benign nature on triple assessment. Reassure and observe small, typical fibroadenomas.Gate: Excise/biopsy if large (>3 cm), rapidly growing or atypical — to exclude a PHYLLODES tumour (which needs wide local excision)
  2. 2Excision for symptomatic/growing lesions or patient choice; routine follow-up not usually needed for small typical lesions.
Reassurance / observationmost need no treatment; many regress
Excisionfor large/growing/symptomatic lesions or patient preference

Key points

Young woman + smooth, firm, very mobile painless lump = fibroadenoma ('breast mouse') → reassure after triple assessment. A rapidly enlarging fibroepithelial lump is phyllodes until excised.

Monitor & prognosis

Interval ultrasound if observed; growth.

Benign; often regresses.

Source: NICE NG101; CKS Breast